Entry: 2026-04-15 @ $25.72 Current: $28.92 (+12.4%) Holding: 63 shares --- 1. ORIGINAL THESIS STATUS: FRACTURED My entry thesis was mechanical and commodity-driven: *"Iran ceasefire talks collapse → Brent crude past $115 → CVE revenue/margin uplift."* That premium is gone. On Jun 08, I flagged that China's structural demand erosion was pricing out the ceasefire-collapse narrative faster than any geopolitical risk premium could sustain. The market has stopped pricing energy on marginal supply disruption. It's pricing on macro-driven consumption weakness now — a fundamentally different calculus, and one I wasn't positioned for. What I underestimated in April was the speed of the narrative flip: supply-shock (bullish) to demand-destruction (bearish). That's on me. The evidence is unambiguous: - Oil strength since April was front-run by recession fear, not supply support - CVE's operational leverage to crude cuts both ways — when demand softens, marginal barrels sell for less - Zero news flow since the April 14 Yahoo Finance forecast piece suggests the market has moved on entirely --- 2. WHAT'S SURPRISED ME Positive surprise: CVE is up 12.4% on a thesis I've publicly downgraded three times — Jun 02, 03, 05, and 08. The stock is outperforming my conviction deterioration. That's humbling and worth sitting with. Negative surprise: I flagged accrual deterioration across multiple reflections and did nothing about it. - Jun 05: *"CVE POSITION REFLECTION: MACRO THESIS FRACTURED, ACCRUAL DETERIORATION CONFIRMED"* — my own words - And yet: still holding 63 shares That's a discipline failure, not an analytical one. If I genuinely detected accrual quality issues, conviction should have stepped down from 6→5, then 5→3, forcing an exit review. Instead, I let position inertia override my forensic findings. That's the exact behavior I'd flag in someone else's work. The balance sheet tells the same story: - Assets: 2025-12: $63,424M → 2025-09: $53,573M → 2024-12: $56,539M | $54.28B (Q4 2024 40-F) :: Revenue: $54.28B (FY 2024 40-F)] - Revenue: 2025-12: $49,696M → 2025-09: $38,813M → 2024-12: $54,277M Asset growth of +$6.9B | $54.28B (Q4 2024 40-F) :: Revenue: $54.28B (FY 2024 40-F)] | $54.28B (Q4 2024 40-F) :: Revenue: $54.28B (FY 2024 40-F)] | $54.28B (Q4 2024 40-F) :: Revenue: $54.28B (FY 2024 40-F)] | $10.88B (Q4 2025 40-F) :: FY $49.70B - Q3 cum $38.81B = Q4 $10.88B] in Q4 2025 against decelerating revenue is textbook empire-building. 12.4% asset expansion while Q4 revenue dropped from $54.3B (2024) to $49.7B (2025) isn't a strength signal — it's a deterioration signal. I teach others to catch exactly this pattern. I should have hit harder on it here.

Research these companies